Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

Kyle B. Matchett; Ivan V. Grishagin; Laura M. Kettyle; Gerald Gavory; Timothy Harrison; Ken Mills; Alexander Thompson

Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

Kyle B. Matchett, Ivan V. Grishagin, Laura M. Kettyle, Gerald Gavory, Timothy Harrison, Ken Mills, Alexander Thompson

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	121-122
Number of pages	1
Publication status	Published - 01 Apr 2016
Event	XXXVI World Congress International Society of Haematology - Glasgow, United Kingdom Duration: 18 Apr 2016 → 21 Apr 2016

Conference

Conference	XXXVI World Congress International Society of Haematology
Country/Territory	United Kingdom
City	Glasgow
Period	18/04/2016 → 21/04/2016

Cite this

@conference{f6e7daf9240442a8bcda33e3bd888ccf,

title = "Mebendazole: A candidate FDA approved drug for repurposing in leukaemia",

author = "Matchett, {Kyle B.} and Grishagin, {Ivan V.} and Kettyle, {Laura M.} and Gerald Gavory and Timothy Harrison and Ken Mills and Alexander Thompson",

year = "2016",

month = apr,

day = "1",

language = "English",

pages = "121--122",

note = "XXXVI World Congress International Society of Haematology ; Conference date: 18-04-2016 Through 21-04-2016",

}

Mebendazole: A candidate FDA approved drug for repurposing in leukaemia. / Matchett, Kyle B.; Grishagin, Ivan V.; Kettyle, Laura M.; Gavory, Gerald; Harrison, Timothy ; Mills, Ken; Thompson, Alexander.

2016. 121-122 Abstract from XXXVI World Congress International Society of Haematology, Glasgow, United Kingdom.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

AU - Matchett, Kyle B.

AU - Grishagin, Ivan V.

AU - Kettyle, Laura M.

AU - Gavory, Gerald

AU - Harrison, Timothy

AU - Mills, Ken

AU - Thompson, Alexander

PY - 2016/4/1

Y1 - 2016/4/1

M3 - Abstract

SP - 121

EP - 122

T2 - XXXVI World Congress International Society of Haematology

Y2 - 18 April 2016 through 21 April 2016

ER -